UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2013

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
____________________

Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 5.07 Submission of Matters to a Vote of Security Holders.

     On November 20, 2013, The Clorox Company (the “Company”) held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:

      1.       The Company stockholders re-elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.

Number of Votes
      For       Against       Abstain       Broker Non-Votes
Daniel Boggan, Jr. 82,324,349 1,695,733 442,725 27,309,900
Richard H. Carmona 81,739,470 2,286,106 437,231 27,309,900
Tully M. Friedman 81,146,985 2,877,252 438,570 27,309,900
George J. Harad 82,006,794 2,018,305 437,708 27,309,900
Donald R. Knauss 80,562,044 2,903,414 997,349   27,309,900
Esther Lee 83,683,927   352,154 426,726 27,309,900
Robert W. Matschullat   81,237,803 2,789,091 435,913 27,309,900
Jeffrey Noddle 83,664,283 360,747 437,777 27,309,900
Rogelio Rebolledo 83,645,736 371,376 445,696 27,309,900
Pamela Thomas-Graham 83,709,175 322,706 430,926 27,309,900
Carolyn M. Ticknor 83,518,063 514,149 430,595 27,309,900

      2.       The Company’s stockholders voted for (on an advisory basis) the compensation of the Company’s named executive officers.

Number of Votes
      For       Against       Abstain       Broker Non-Votes
77,807,307 5,707,565 947,935   27,309,900

      3.       The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2014.

Number of Votes
      For       Against       Abstain       Broker Non-Votes
110,339,134   815,522   618,051   0


SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

      THE CLOROX COMPANY
  
Date: November 22, 2013 By:          /s/ Laura Stein
         Senior Vice President –
     General Counsel